TrovaGene
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TrovaGene and buy or sell other stocks, ETFs, and their options commission-free!About TROV
Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. It is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics.
CEOMark Erlander, PhD
CEOMark Erlander, PhD
Employees33
Employees33
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1999
Founded1999
Employees33
Employees33
TROV Key Statistics
Market cap79.17M
Market cap79.17M
Price-Earnings ratio-3.12
Price-Earnings ratio-3.12
Dividend yield—
Dividend yield—
Average volume787.67K
Average volume787.67K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.64
52 Week high$5.64
52 Week low$2.01
52 Week low$2.01
People also own
Based on the portfolios of people who own TROV. This list is generated using Robinhood data, and it’s not a recommendation.